Spectral AI was recognized for its DeepView System, an AI-driven, predictive diagnostic device and associated software platform that combines multispectral imaging with a proprietary AI algorithm to assess the healing potential of burn wounds. The DeepView System provides clinicians with an immediate, data-driven assessment of whether a burn wound will heal on its own or requires significant medical intervention, enabling earlier and more informed treatment decisions. Spectral AI submitted its De Novo clearance application for the DeepView System to the U.S. Food and Drug Administration in June 2025.
u/New_Book_9785 — 14 days ago